
Opinion|Videos|November 8, 2024
Personalizing Treatments and Patient Education
Key Takeaways
- Personalizing treatment regimens involves adjusting dosing schedules and administration routes to improve adherence and quality of life.
- Evaluating patient-specific factors, such as lifestyle and preferences, is crucial in developing personalized treatment plans.
Panelists discuss how treatment regimens for multiple myeloma patients can be personalized to improve adherence and quality of life by considering factors such as dosing schedules and routes of administration while emphasizing the role of pharmacists in providing resources and support to keep patients informed, engaged, and compliant with their individualized treatment plans.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How can a patient's treatment regimen be personalized to improve adherence and quality of life (eg, dosing schedule, route of administration), and how are those factors weighed or evaluated when developing treatment plans?
- (Dr Adams) What resources or support can pharmacists offer to keep patients informed, engaged, and compliant with their treatment plans?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market
4
The Return of Belantamab Mafodotin: Past Lessons, Present Promise, and Future Impact
5
















































































































































































































